Skip to main content
Premium Trial:

Request an Annual Quote

Olink Proseek Multiplex Oncology II<sup>96x96</sup>

Olink Bioscience has launched Proseek Multiplex Oncology II96x96, a new human protein biomarker panel for cancer research. This product is part of the ongoing development of the Proseek platform, expanding the library of unique biomarkers available and complementing existing panels directed against cardiovascular and inflammatory diseases, the company said in a statement. The panel offers high-throughput multiplex immunoassays that measure 92 cancer-related proteins across 96 samples simultaneously using only one microliter of serum, plasma, or almost any other type of biological sample. Proseek Multiplex is based on the proprietary proximity extension assay technology developed by Olink. The new panel improves on Proseek Multiplex Oncology 1 v296x96 by offering 60 completely new oncology-focused biomarker assays.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.